$0.00
(+0.00%
) Quote details
USD
+$0.00
(+0.00%
)At Close (As of Dec 16, 2025)
$17.28M
Market Cap
0.207
P/E Ratio
5.75
EPS
$2.06
52 Week High
$0.61
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Allarity Therapeutics Inc. is a clinical-stage biopharmaceutical company headquartered in Denmark, dedicated to innovating cancer treatment through its proprietary drug response prediction technology. By developing precision therapies that are paired with robust diagnostics, the company focuses on personalized medicine to optimize treatment outcomes for individual patients. Allarity is well-positioned to enhance oncology care and improve patient results, establishing its presence as a key player in the evolving landscape of cancer therapeutics. With a commitment to matching therapies with patients most likely to benefit, Allarity aims to transform cancer treatment through targeted approaches.
LPTX
VMAR
IVP
NVDA
CGC
PFE
TSLA
WOK
AAL
PLUG
ASST
WBD
IRBT
RZLV
F
AVGO
ADAP
INTC
PLTD
SNAP
TLRY
BYND
BITF
DFLI
IREN
RIG
SOFI
CIFR
PLTR
MARA
GRAB
CRBG
DNN
T
NFLX
ALIT
HPE
APLD
BAC
ORCL
PBR
WULF
GOOGL
CPNG
LAZR
VHAI
PCG
BTBT
RGTI
NIO
QBTS
VALE
RILY
AMC
CORZ
UBER
KVUE
HBAN
NOK
AMD
VZ
RKLB
CCL
CLSK
MU
GOOG
MSTR
ITUB
HOOD
RR
SMCI
LPTX
VMAR
IVP
NVDA
CGC
PFE
TSLA
WOK
AAL
PLUG
ASST
WBD
IRBT
RZLV
F
AVGO
ADAP
INTC
PLTD
SNAP
TLRY
BYND
BITF
DFLI
IREN
RIG
SOFI
CIFR
PLTR
MARA
GRAB
CRBG
DNN
T
NFLX
ALIT
HPE
APLD
BAC
ORCL
PBR
WULF
GOOGL
CPNG
LAZR
VHAI
PCG
BTBT
RGTI
NIO
QBTS
VALE
RILY
AMC
CORZ
UBER
KVUE
HBAN
NOK
AMD
VZ
RKLB
CCL
CLSK
MU
GOOG
MSTR
ITUB
HOOD
RR
SMCI